These tests deliver results in 10–15 minutes at a cost of Rs 100–Rs 150, compared to conventional diagnostics which cost up to Rs 15,000
The national platform brought together healthcare professionals, patient advocates, and stakeholders
The approval now covers procedures using 10-14F inner diameter and up to 17F outer diameter procedural sheaths
The EU approval of DAWNZERA is an important milestone that reflects our ongoing commitment to bring this innovative medicine to people in need across the globe
Richard A. Gonzalez to retire from the board of directors effective July 1, 2025
Ibara will drive AI-powered clinical research innovation
Sunrise is built on four elements i.e., Awareness, Screening & Diagnosis, Treatment, and Maintenance Support
Heavy bleeding after giving birth is globally a leading cause of death in new mothers
Company to manufacture drug substance for clinical supply of HaemaLogiX’s lead multiple myeloma drug candidate, KappaMab, at its new state-of-the-art facility in Guangzhou, China
PPH is associated with almost 20 per cent of maternal mortality in India
Subscribe To Our Newsletter & Stay Updated
